When can low-dose aspirin be started in pregnancy?

When to Start Low-Dose Aspirin in Pregnancy

Low-dose aspirin (75-81 mg daily) should be started between 12-16 weeks of gestation in pregnant women at high risk for preeclampsia, with emerging evidence supporting initiation before 12 weeks for optimal benefit.

Risk Assessment and Timing

High-Risk Factors Requiring Aspirin Prophylaxis

Multiple major guidelines consistently identify women who should receive low-dose aspirin 1:

High-risk conditions (any one qualifies):

• History of preeclampsia, especially early-onset (<34 weeks) or in multiple pregnancies
• Chronic hypertension
• Type 1 or Type 2 diabetes
• Chronic kidney disease
• Autoimmune disease (e.g., lupus, antiphospholipid syndrome)
• Multifetal gestation

Moderate-risk factors (≥2 factors required):

• First pregnancy
• Maternal age ≥40 years
• Pregnancy interval >10 years
• BMI ≥35 kg/m²
• Family history of preeclampsia

Optimal Timing Window

The guideline-recommended initiation window is 12-16 weeks of gestation 2, 1. ACOG endorsed the USPSTF recommendation to start aspirin between 12-28 weeks, though earlier initiation within this range is preferred 2.

Critical timing considerations:

• Before 16 weeks is superior: Studies show aspirin initiated before 16 weeks provides significantly better outcomes than later initiation 2, 1
• Before 12 weeks may be optimal: Recent high-quality research demonstrates that initiation before 12 weeks (versus 12-20 weeks) substantially reduces gestational hypertension (6.1% vs 24.9%), preeclampsia (4.2% vs 15.6%), and preterm birth before 32 weeks (0.3% vs 7.0%) 3, 4
• After 20 weeks loses efficacy: Meta-analysis shows aspirin started after 20 weeks does not significantly reduce preeclampsia risk 5

Dosing Recommendations

Standard dose: 75-81 mg daily 1

• USPSTF and most U.S. guidelines recommend 81 mg daily 1
• WHO and NICE recommend 75 mg daily 1
• Some evidence suggests 150 mg may provide additional benefit in very high-risk women, though this requires further validation 6, 7

Duration of Treatment

Continue aspirin until delivery 1. Some protocols suggest discontinuation at 36 weeks, though most guidelines recommend continuation until birth 7.

Safety Profile

Low-dose aspirin at these doses and timing has a favorable safety profile 1, 5:

• No increased risk of postpartum hemorrhage
• No increased placental abruption risk
• No adverse fetal effects when used at recommended doses
• The FDA warning about aspirin in pregnancy refers to high-dose analgesic use, not low-dose prophylaxis 8

Common Pitfalls to Avoid

1. Starting too late: Waiting until after 16 weeks significantly reduces efficacy
2. Confusing high-dose warnings with low-dose prophylaxis: FDA warnings about aspirin in the third trimester apply to analgesic doses (>325 mg), not prophylactic low-dose aspirin 8
3. Missing moderate-risk patients: Women with ≥2 moderate risk factors benefit equally from aspirin prophylaxis 1
4. Stopping prematurely: Discontinuing before 36 weeks may reduce protective effect

Practical Implementation Algorithm

1. At first prenatal visit (ideally <12 weeks):

   • Screen for high-risk factors
   • If any high-risk factor present OR ≥2 moderate-risk factors: prescribe aspirin 81 mg daily

2. Initiate aspirin immediately if <16 weeks

   • Ideally before 12 weeks based on recent evidence 3, 4
   • Still beneficial if started between 12-16 weeks 2

3. Continue daily until delivery

   • May consider stopping at 36 weeks in consultation with patient
   • Do not stop earlier unless contraindication develops